HIV's genome of RNA includes the code for reverse transcriptase (RT), an enzyme that acts early in infection to synthesize a DNA genome off of an RNA template. The HIV genome also codes for protease (PR), an enzyme that acts later in infection by cutting long viral polyproteins into smaller, functional proteins. Both RT and PR represent potential targets for antiretroviral drugs. Drugs called nucleoside analogs (NA) act against RT, whereas drugs called protease inhibitors (PI) act against PR.

HIV's genome of RNA includes the code for reverse transcriptase (RT), an enzyme that acts early in infection to synthesize a DNA genome off of an RNA template. The HIV genome also codes for protease (PR), an enzyme that acts later in infection by cutting long viral polyproteins into smaller, functional proteins. Both RT and PR represent potential targets for antiretroviral drugs. Drugs called nucleoside analogs (NA) act against RT, whereas drugs called protease inhibitors (PI) act against PR. 




Which of the following represents the treatment option most likely to avoid the production of drug-resistant HIV (assuming no drug interactions or side effects)? 

A) using a series of NAs, one at a time, and changed about once a week
B) using a single PI, but slowly increasing the dosage over the course of a week
C) using high doses of NA and a PI at the same time for a period not to exceed one day
D) using moderate doses of NA and two different PIs at the same time for several months


Answer: D


Within the body of an HIV-infected individual who is being treated with a single NA, and whose HIV particles are currently vulnerable to this NA, which of these situations can increase the virus' relative fitness? 

1. mutations resulting in RTs with decreased rates of nucleotide mismatch
2. mutations resulting in RTs with increased rates of nucleotide mismatch
3. mutations resulting in RTs that have proofreading capability

A) 1 only
B) 2 only
C) 3 only
D) 1 and 3
E) 2 and 3


Answer: B


HIV has nine genes in its RNA genome. Every HIV particle contains two RNA molecules, and each molecule contains all nine genes. If, for some reason, the two RNA molecules within a single HIV particle do not have identical sequences, then which of these terms can be applied due to the existence of the nonidentical regions? 



A) homozygous
B) gene variability
C) nucleotide variability
D) average heterozygosity
E) All but one of the responses are correct.


Answer: E


Every HIV particle contains two RNA molecules. If two genes from one RNA molecule become detached and then, as a unit, get attached to one end of the other RNA molecule within a single HIV particle, which of these is true?

 

A) There are now fewer genes within the viral particle.
B) There are now more genes within the viral particle.
C) A point substitution mutation has occurred in the retroviral genome.
D) The retroviral equivalent of crossing over has occurred, no doubt resulting in a heightened positive effect.
E) One of the RNA molecules has experienced gene duplication as the result of translocation.


Answer: E


In a hypothetical population's gene pool, an autosomal gene, which had previously been fixed, undergoes a mutation that introduces a new allele, one inherited according to incomplete dominance. Natural selection then causes stabilizing selection at this locus. Consequently, what should happen over the course of many generations? 


A) The proportions of both types of homozygote should decrease.
B) The proportion of the population that is heterozygous at this locus should remain constant.
C) The population's average heterozygosity should decrease.
D) The two homozygotes should decrease at different rates.


Answer: A